MELARIS® is a genetic test that requires only a small blood sample to determine if a patient has a p16 gene mutation, indicating a predisposition for melanoma and pancreatic cancer. Once genetic risk is identified, there are
specific management strategies that can be employed for early
detection, risk reduction, and possible prevention.
Benefits of Genetic
Testing
Not only does MELARIS®
genetic testing enable the physician to take a proactive management
approach with clearly identified at-risk patients, but it can also
enable clinicians to:
Avoid unnecessary interventions in family
members who did not test positive for the gene mutation
Target screening and surveillance to only
those with the p16 gene mutation — increasing clinical
efficiency while saving costs
Counsel patients and family members on the
underlying cause of cancer.
Finally, if cancer does develop,
outcomes are likely to be significantly improved and medical costs
reduced by early diagnosis and treatment.
The Myriad Genetic
Laboratories Advantages
Myriad Genetic Laboratories
offers the most accurate clinical test available
to detect p16 gene mutations. Myriad Genetic Laboratories
offers:
Proprietary automated robotics systems help
decrease the chance of human error in the analysis and ensures
specimen integrity
The Myriad Reimbursement Assistance Program
(MRAP) assists patients in maximizing their payment options for
genetic testing
For more information
on MELARIS®, the genetic test for patients who may have a predisposition
for melanoma and pancreatic cancer, call Myriad
Genetic Laboratories at 800-469-7423.
Order a testing kit
online.
